http://www.healthtopics.ws/alzheimer/biomarkers-of-inflammation-and-amyloid-beta-phagocytosis-in-patients-at-risk-of-alzheimer-disease-/ Authors: Fiala M, Veerhuis R The ultimate goal of diagnostic research is a blood test detecting the risk of Alzheimer disease (AD) before neuronal damage develops. Current amyloid-beta(Abeta) tests do not detect the process leading to neurodegeneration. Novel immunologic and proteomics tests are based on aberrant appearance of inflammatory cytokines in the CSF and other protein biomarkers... Wed, 26 Aug 2009 13:15:08 CEST en